These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1833245)

  • 21. Sex steroid levels during treatment of endometriosis.
    Hirschowitz JS; Soler NG; Wortsman J
    Obstet Gynecol; 1979 Oct; 54(4):448-50. PubMed ID: 492624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiendometrial antibodies in endometriosis measured by an enzyme-linked immunosorbent assay before and after treatment with danazol and nafarelin.
    Kennedy SH; Starkey PM; Sargent IL; Hicks BR; Barlow DH
    Obstet Gynecol; 1990 Jun; 75(6):914-8. PubMed ID: 2140439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.
    Schmidt-Sarosi C; Kaplan DR; Sarosi P; Essig MN; Licciardi FL; Keltz M; Levitz M
    J Assist Reprod Genet; 1995 Mar; 12(3):167-74. PubMed ID: 8520180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of danazol on pulsatile gonadotropin secretion in women with endometriosis.
    Maouris P; Dowsett M; Edmonds DK; Sullivan D
    Fertil Steril; 1991 May; 55(5):890-4. PubMed ID: 1902419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-related changes in LH bioactivity with intranasal GnRH agonist administration.
    Chiang RS; Barnes RB; Shoupe D; Lobo RA
    Contraception; 1985 Oct; 32(4):347-57. PubMed ID: 2934222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nafarelin in the treatment of pelvic pain caused by endometriosis.
    Shaw RW
    Am J Obstet Gynecol; 1990 Feb; 162(2):574-6. PubMed ID: 2137972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect on corpus luteum function of luteal phase administration of a potent gonadotropin-releasing hormone analog (nafarelin).
    Schriock ED; Monroe SE; Martin MC; Henzl MR; Jaffe RB
    Fertil Steril; 1985 Jun; 43(6):844-50. PubMed ID: 3158549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of danazol and the LHRH agonist analogue goserelin (Zoladex) on the biological activity of luteinizing hormone in women with endometriosis.
    Maouris P; Dowsett M; Rose G; Edmonds DK; Rothwell C; Robertson WR
    Clin Endocrinol (Oxf); 1990 Oct; 33(4):539-46. PubMed ID: 2146047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the pharmacology of nafarelin and danazol.
    Barbieri RL
    Am J Obstet Gynecol; 1990 Feb; 162(2):581-5. PubMed ID: 2137975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal, metabolic and clinical effects of danazol in the treatment of endometriosis.
    Rannevik G
    Postgrad Med J; 1979; 55 Suppl 5():14-20. PubMed ID: 537948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis.
    Ylikorkala O; Nilsson CG; Hirvonen E; Viinikka L
    Gynecol Endocrinol; 1990 Dec; 4(4):251-60. PubMed ID: 2150580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nafarelin versus danazol versus surgery.
    Redwine DB
    Fertil Steril; 1992 Aug; 58(2):455-6. PubMed ID: 1386034
    [No Abstract]   [Full Text] [Related]  

  • 33. A prospective randomized comparison of routine buserelin acetate and a decreasing dosage of nafarelin acetate with a low-dose gonadotropin-releasing hormone agonist protocol for in vitro fertilization and intracytoplasmic sperm injection.
    Takeuchi S; Minoura H; Shibahara T; Tsuiki Y; Noritaka F; Toyoda N
    Fertil Steril; 2001 Sep; 76(3):532-7. PubMed ID: 11532477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone mineral density in women with endometriosis before and during ovarian suppression with gonadotropin-releasing hormone agonists or danazol.
    Tummon IS; Ali A; Pepping ME; Radwanska E; Binor Z; Dmowski WP
    Fertil Steril; 1988 May; 49(5):792-6. PubMed ID: 3129312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nafarelin in the management of endometriosis: quality of life assessment.
    Burry KA
    Am J Obstet Gynecol; 1992 Feb; 166(2):735-9. PubMed ID: 1531576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic findings and hormonal patterns in the treatment of endometriosis by danazol.
    Tolino A; Romano L; Chiacchio G; Ronsini S; Montemagno U
    Acta Eur Fertil; 1987; 18(2):85-9. PubMed ID: 2957884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nafarelin in the treatment of infertility caused by endometriosis.
    Barlow DH
    Am J Obstet Gynecol; 1990 Feb; 162(2):576-9. PubMed ID: 2137973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal nafarelin: an LH-RH analogue treatment of gonadotropin-dependent precocious puberty.
    Lin TH; LePage ME; Henzl M; Kirkland JL
    J Pediatr; 1986 Dec; 109(6):954-8. PubMed ID: 2946840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pain of endometriosis: effects of nafarelin and danazol therapy.
    Adamson GD; Kwei L; Edgren RA
    Int J Fertil Menopausal Stud; 1994; 39(4):215-7. PubMed ID: 7951404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of danazol in the management of endometriosis.
    Young MD; Blackmore WP
    J Int Med Res; 1977; 5 Suppl 3():86-91. PubMed ID: 913886
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.